Atea Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $464.7M
Liabilities Breakdown FY2024
Total Liabilities: $25.8M
Asset Breakdown
Total Assets: $464.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $64.7M | 13.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $873.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $399.1M | 85.9% |
Liabilities Breakdown
Total Liabilities: $25.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.5M | 17.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $21.3M | 82.7% |